A non-profit member organization

Andes Biotechnologies

September 21, 2018

Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.

Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.

Email Address *

First Name *

Last Name *

Company *

Country

Which LAVCA Newsletter would you like to receive?

"According to LAVCA Data, VC investment into Latin American fintech totaled USD1.2b in the first quarter of 2022."… https://t.co/oikd3BXiCU

24-Jun-2022

Reply Retweet Favorite
Felicitaciones a la Directora Ejecutiva de LAVCA @lavca_org Ángela María Tafur @naitafur quien se ha incorporado al… https://t.co/qjHgnmFPS3

14-Jun-2022

Reply Retweet Favorite
LAVCA's Director of Venture Capital @crdelavega_ shares insights with @TechCrunch's @bayareawriter on the latest d… https://t.co/krypDTI5NE

14-Jun-2022

Reply Retweet Favorite
Congratulations to LAVCA's Executive Director @naitafur who has joined the Board of Directors of @GRUPOSURA. https://t.co/47bv5fyVhT

13-Jun-2022

Reply Retweet Favorite
In 2018, @_AquaCapital invested in agricultural biologicals platform @Biotropbr. In 3 years, the company has reduce… https://t.co/PDu5zkchTs

13-Jun-2022

Reply Retweet Favorite